Clinical Lab Product's Podcast SeriesCirculating Tumor Cell Detection: CellSearch® Technology from Veridex Special guest: Bob McCormack, Ph.D., vice president of medical and scientific affairs at Veridex, a Johnson and Johnson company. Thursday, March 26, 2009, Part 3 of 3 Topic: and use of CellSearch(R) technology and future of circulating tumor cells as oncology diagnostic. Thursday, March 19, 2009, Part 2 of 3 Topic: The role of circulating tumor cell detection in personalized medicine landscape, including potential effects of recently passed stimulus package. Thursday, March 12, 2009, Part 1 of 3 Topic: Introduction to circulating tumor cells and discussion of study appearing in March issue of Lancet Oncology, demonstrating value of circulating tumor cell detection in prostate cancer patients.
|
 |
Subscribe to this Podcast
Experts here are available to answer all your questions!
ADDITIONAL ONLINE RESOURCES |
 |
|